Optimal prevention strategies for chronic diseases in a compartmental disease trajectory model (2403.14296v3)
Abstract: In countries with growing elderly populations, multimorbidity poses a significant healthcare challenge. Despite its pressing development, important questions remain on how to model the development of multimorbidity. Leveraging a comprehensive dataset from approximately 45 million hospital stays spanning 17 years in Austria, we propose a compartmental model, traditionally used in infectious diseases, describing chronic disease trajectories across 132 distinct multimorbidity patterns (compartments). Our compartmental disease trajectory model (CDTM) forecasts changes in the incidence of 131 diagnostic groups and their combinations until 2030, highlighting patterns involving hypertensive diseases with cardiovascular diseases and metabolic disorders. We additionally use the model to pinpoint specific diagnoses with the greatest potential for preventive interventions to promote healthy aging. According to our model, a 5% reduction in new cases of hypertensive disease (I10-I15) leads to a 0.57 (0.06)% reduction in all-cause mortality over a 15-year period, and a 0.57 (0.07)% reduction in mortality for malignant neoplasms (C00-C97). Furthermore, we use the model to assess the long-term consequences of the Covid-19 pandemic on hospitalizations, revealing earlier and more frequent hospitalizations across multiple diagnoses. Our fully data-driven approach identifies leverage points for proactive preparation by physicians and policymakers to reduce the overall disease burden in the population, emphasizing a shift toward patient-centered care.
- World Health Organization “Global Health Estimates: Life expectancy and leading causes of death and disability” URL: https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-life-expectancy-and-healthy-life-expectancy
- Our World Data “Life Expectancy” URL: https://ourworldindata.org/life-expectancy
- Statistics Austria “Healthy life expectancy”, 2024 URL: https://www.statistik.at/en/statistics/population-and-society/health/health-status/healthy-life-expectancy
- Statistics Austria “Population projections for Austria and federal states”, 2024 URL: https://www.statistik.at/en/statistics/population-and-society/population/demographische-prognosen/population-projections-for-austria-and-federal-states
- “Ageing policies – access to services in different Member States. Country study on Austria (Annex I)”, 2021, pp. 36
- V Raleigh “Trends in life expectancy in EU and other OECD countries: Why are improvements slowing?”, 2019 DOI: https://doi.org/10.1787/223159ab-en
- Statistics Austria “Healthy Life Years at birth since 1978 by self-perceived health status and sex - in years”, 2022 URL: https://www.statistik.at/en/statistics/population-and-society/health/health-status/healthy-life-expectancy
- European Observatory Health Systems and Policies “Austria: Country Health Profile 2021”, 2021 URL: https://eurohealthobservatory.who.int/publications/m/austria-country-health-profile-2021
- “Health System Review 2018”, 2018
- “Morbidity Measures Predicting Mortality in Inpatients: A Systematic Review” In Journal of the American Medical Directors Association 21.4, 2020, pp. 462–468.e7 DOI: 10.1016/j.jamda.2019.12.001
- “Rising to the challenge of multimorbidity” In BMJ, 2020, pp. l6964 DOI: 10.1136/bmj.l6964
- Jonathan Pearson-Stuttard, Majid Ezzati and Edward W Gregg “Multimorbidity—a defining challenge for health systems”, 2019, pp. e599–e600 DOI: 10.1016/S2468-2667(19)30222-1
- “Prevalence of Chronic Diseases and Multimorbidity Among the Elderly Population in Sweden” In American Journal of Public Health 98.7, 2008, pp. 1198–1200 DOI: 10.2105/AJPH.2007.121137
- “Prevalence and patterns of multimorbidity among the elderly in China: a cross-sectional study using national survey data” In BMJ Open 9.8, 2019, pp. e024268 DOI: 10.1136/bmjopen-2018-024268
- “Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany” In BMC Public Health 11.1, 2011, pp. 101 DOI: 10.1186/1471-2458-11-101
- Martin Fortin, Catherine Hudon and Jeannie Haggerty “RPerseearvchaalrteicnle ce estimates of multimorbidity: a comparative study of two sources”, 2010, pp. 6
- “The increasing burden and complexity of multimorbidity”, 2015, pp. 11
- Miguel J. Divo, Carlos H. Martinez and David M. Mannino “Ageing and the epidemiology of multimorbidity” In European Respiratory Journal 44.4, 2014, pp. 1055–1068 DOI: 10.1183/09031936.00059814
- “Examining variation in the measurement of multimorbidity in research: a systematic review of 566 studies” In The Lancet Public Health 6.8, 2021, pp. e587–e597 DOI: 10.1016/S2468-2667(21)00107-9
- Kathryn Nicholson, José Almirall and Martin Fortin “The measurement of multimorbidity.” Place: US Publisher: American Psychological Association In Health Psychology 38.9, 2019, pp. 783–790 DOI: 10.1037/hea0000739
- Anna Chmiel, Peter Klimek and Stefan Thurner “Spreading of diseases through comorbidity networks across life and gender” In New Journal of Physics 16.11, 2014, pp. 115013 DOI: 10.1088/1367-2630/16/11/115013
- “High-risk multimorbidity patterns on the road to cardiovascular mortality” In BMC Medicine 18.1, 2020, pp. 44 DOI: 10.1186/s12916-020-1508-1
- “A Dynamic Network Approach for the Study of Human Phenotypes” In PLoS Computational Biology 5.4, 2009, pp. e1000353 DOI: 10.1371/journal.pcbi.1000353
- “Identifying temporal patterns in patient disease trajectories using dynamic time warping: A population-based study” In Scientific Reports, 2018 DOI: https://doi.org/10.1038/s41598-018-22578-1
- “A system-level analysis of patient disease trajectories based on clinical, phenotypic and molecular similarities”, 2020 DOI: 10.1093/bioinformatics/btaa964
- “Identifying Temporal Patterns in Healthcare Service-Use Trajectories of Long-Term Breast Cancer Survivors” In Proceedings of the 11th Annual Symposium on Global Cancer Research; Closing the Research-to-Implementation Gap, 2023
- “Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients” In NATURE COMMUNICATIONS, 2014
- “Network-based analysis of diagnosis progression patterns using claims data” In Scientific Reports 7.1, 2017, pp. 15561 DOI: 10.1038/s41598-017-15647-4
- “Statistical methods for constructing disease comorbidity networks from longitudinal inpatient data” In Applied Network Science 3.1, 2018, pp. 46 DOI: 10.1007/s41109-018-0101-4
- “Using Electronic Patient Records to Discover Disease Correlations and Stratify Patient Cohorts” In PLoS Computational Biology 7.8, 2011
- “A Large-Cohort, Longitudinal Study Determines Precancer Disease Routes across Different Cancer Types” In Cancer Research, 2019
- Amalie D Haue, JJ Armenteros and P.C. Holm “Temporal patterns of multi-morbidity in 570157 ischemic heart disease patients: a nationwide cohort study”, 2022 DOI: https://doi.org/10.1186/s12933-022-01527-3
- “Diagnosis trajectories of prior multi-morbidity predict sepsis mortality” In Scientific Reports, 2016 DOI: https://doi.org/10.1038/srep36624
- “Using sequences of life-events to predict human lives”, 2024 DOI: https://doi.org/10.1038/s43588-023-00573-5
- “Multimorbidity and comorbidity in the Dutch population – data from general practices” In BMC Public Health 12.1, 2012, pp. 715 DOI: 10.1186/1471-2458-12-715
- Annemarie A. Uijen and Eloy H. Lisdonk “Multimorbidity in primary care: Prevalence and trend over the last 20 years” In European Journal of General Practice 14.sup1, 2008, pp. 28–32 DOI: 10.1080/13814780802436093
- “The prevalence of complex multimorbidity in Australia” In Australian and New Zealand Journal of Public Health 40.3, 2016, pp. 239–244 DOI: 10.1111/1753-6405.12509
- Andrew Kingston, Adelina Comas-Herrera and Carol Jagger “Forecasting the care needs of the older population in England over the next 20 years: estimates from the Population Ageing and Care Simulation (PACSim) modelling study” In The Lancet Public Health 3.9, 2018, pp. e447–e455 DOI: 10.1016/S2468-2667(18)30118-X
- “Projections of multi-morbidity in the older population in England to 2035: estimates from the Population Ageing and Care Simulation (PACSim) model” In Age and Ageing 47.3, 2018, pp. 374–380 DOI: 10.1093/ageing/afx201
- Barbara Fletcher, Meg Gulanick and Cindy Lamendola “Risk Factors for Type 2 Diabetes Mellitus:” In The Journal of Cardiovascular Nursing 16.2, 2002, pp. 17–23 DOI: 10.1097/00005082-200201000-00003
- “Diabetic Neuropathies: Diagnosis and Management” In Neuroendocrinology 98.4, 2013, pp. 267–280 DOI: 10.1159/000358728
- Statistics Austria “Demographisches Jahrbuch 2019”, 2019
- “COVID-19: Daten Covid19-Fälle je Altergruppe”, 2024 URL: https://www.data.gv.at/katalog/dataset/covid-19-daten-covid19-faelle-je-altergruppe
- Statistics Austria “Causes of death”, 2024 URL: https://www.statistik.at/en/statistics/population-and-society/population/deaths/causes-of-death
- Statistics Austria “Projected population structure for Austria 2020-2080”, 2022 URL: https://www.statistik.at/en/statistics/population-and-society/population/demographische-prognosen/population-projecions-for-austria-and-federal-states
- “Patterns of Multimorbidity in the Aged Population. Results from the KORA-Age Study” In PLoS ONE 7.1, 2012
- Marcel E. Salive “Multimorbidity in Older Adults”, 2013 DOI: 10.1093/epirev/mxs009
- “Multimorbidity prevalence and patterns in chronic kidney disease: findings from an observational multicentre UK cohort study” In International Urology and Nephrology 55.8, 2023, pp. 2047–2057 DOI: 10.1007/s11255-023-03516-1
- “Costs of multimorbidity: a systematic review and meta-analyses”, 2022 DOI: https://doi.org/10.1186/s12916-022-02427-9
- “Sex Differences in Cardiovascular Outcomes in CKD: Findings From the CRIC Study” In American Journal of Kidney Diseases 78.2, 2021, pp. 200–209.e1 DOI: 10.1053/j.ajkd.2021.01.020
- Kaitlin J. Mayne, Michael K. Sullivan and Jennifer S. Lees “Sex and gender differences in the management of chronic kidney disease and hypertension” In Journal of Human Hypertension 37.8, 2023, pp. 649–653 DOI: 10.1038/s41371-023-00843-9
- “Global Disease Burden (GBD Compare)” URL: https://vizhub.healthdata.org/gbd-compare/
- “Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries” In Circulation 134.6, 2016, pp. 441–450 DOI: 10.1161/CIRCULATIONAHA.115.018912
- “Sex differences in the association of risk factors for heart failure incidence and mortality”, 2020, pp. 203–12 DOI: 10.1136/heartjnl-2019-314878
- “Women, power, and cancer: a Lancet Commission” In The Lancet 402.10417, 2023, pp. 2113–2166 DOI: 10.1016/S0140-6736(23)01701-4
- “Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality” In New England Journal of Medicine 389.14, 2023, pp. 1273–1285 DOI: 10.1056/NEJMoa2206916
- “Gender gap in risk factor control of coronary patients far from closing: results from the European Society of Cardiology EUROASPIRE V registry” In European Journal of Preventive Cardiology 29.2, 2022, pp. 344–351 DOI: 10.1093/eurjpc/zwaa144
- Alexandra Kautzky-Willer, Michael Leutner and Jürgen Harreiter “Sex differences in type 2 diabetes” In Diabetologia 66.6, 2023, pp. 986–1002 DOI: 10.1007/s00125-023-05891-x
- “Gender differences in cardiovascular risk, treatment, and outcomes: a post hoc analysis from the REWIND trial” In Scandinavian Cardiovascular Journal 57.1, 2023, pp. 2166101 DOI: 10.1080/14017431.2023.2166101
- “Sex- and Gender-Based Pharmacological Response to Drugs” In Pharmacological Reviews 73.2, 2021, pp. 730–762 DOI: 10.1124/pharmrev.120.000206
- AK Singh and Singh “Gender difference in cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in type 2 diabetes: A systematic review and meta-analysis of cardio-vascular outcome trials”, 2020 DOI: 10.1016/j.dsx.2020.02.012
- “Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention” In American Journal of Cardiovascular Drugs 23.5, 2023, pp. 477–495 DOI: 10.1007/s40256-023-00594-5
- Patrick Müller, Melvin Khee-Shing Leow and Johannes W. Dietrich “Minor perturbations of thyroid homeostasis and major cardiovascular endpoints—Physiological mechanisms and clinical evidence” In Frontiers in Cardiovascular Medicine 9, 2022, pp. 942971 DOI: 10.3389/fcvm.2022.942971
- “Thyroid disorders and cardiovascular manifestations: an update” In Endocrine 75.3, 2022, pp. 672–683 DOI: 10.1007/s12020-022-02982-4
- “Endocrine Disorders and Peripheral Arterial Disease - A Series of Reviews Cushing Syndrome-Cortisol Excess” In Curr Vasc Pharmacol, 2023 DOI: 10.2174/0115701611272145231106053914
- “Epidemiology and Genetics of Venous Thromboembolism and Chronic Venous Disease” In Circulation Research 128.12, 2021, pp. 1988–2002 DOI: 10.1161/CIRCRESAHA.121.318322
- “Analysis of National Trends in Admissions for Pulmonary Embolism” In Chest 150.1, 2016, pp. 35–45 DOI: 10.1016/j.chest.2016.02.638
- Ziyad Al-Aly, Yan Xie and Benjamin Bowe “High-dimensional characterization of post-acute sequelae of COVID-19” In Nature 594.7862, 2021, pp. 259–264 DOI: 10.1038/s41586-021-03553-9
- “Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study” In BMJ, 2021, pp. n1098 DOI: 10.1136/bmj.n1098
- Evan Xu, Yan Xie and Ziyad Al-Aly “Long-term neurologic outcomes of COVID-19” In Nature Medicine, 2022 DOI: 10.1038/s41591-022-02001-z
- Yan Xie, Evan Xu and Ziyad Al-Aly “Risks of mental health outcomes in people with covid-19: cohort study” In BMJ, 2022, pp. e068993 DOI: 10.1136/bmj-2021-068993
- “Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study” In The Lancet 380.9836, 2012, pp. 37–43 DOI: 10.1016/S0140-6736(12)60240-2
- “Multimorbidity” In Nature Reviews Disease Primers 8.1, 2022, pp. 48 DOI: 10.1038/s41572-022-00376-4
- Evan Xu, Yan Xie and Ziyad Al-Aly “Long-term gastrointestinal outcomes of COVID-19” In Nature Communications 14.1, 2023, pp. 983 DOI: 10.1038/s41467-023-36223-7